Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.356 EUR | 0.00% | 0.00% | -3.52% |
04/03 | Mib above 32,900; Saipem on top after OPEC cuts | AN |
04/03 | Stock markets down; on Mib well DiaSorin post FDA decision | AN |
Valuation
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Capitalization 1 | 3.762 | 0.6814 | 0.2258 | 2.761 | 0.8674 | 0.1654 |
Enterprise Value (EV) 1 | 6.364 | 2.819 | 2.066 | 4.314 | 2.666 | 1.346 |
P/E ratio | - | - | -1.22 x | -3.59 x | -0.27 x | -0.26 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 1.06 x | 0.18 x | 0.05 x | 0.65 x | 0.21 x | 0.04 x |
EV / Revenue | 1.79 x | 0.76 x | 0.48 x | 1.01 x | 0.66 x | 0.32 x |
EV / EBITDA | 56.2 x | 35.8 x | -1.67 x | 1,010 x | -9.13 x | - |
EV / FCF | -7.67 x | -4.68 x | - | -3.17 x | - | 2.09 x |
FCF Yield | -13% | -21.4% | - | -31.6% | - | 47.8% |
Price to Book | - | - | 1.07 x | 0.89 x | 8.18 x | 31.2 x |
Nbr of stocks (in thousands) | 2.43 | 4.01 | 6.56 | 226 | 291 | 1,654 |
Reference price 2 | 1,548 | 170.0 | 34.40 | 12.20 | 2.980 | 0.1000 |
Announcement Date | 23/11/18 | 10/05/19 | 10/06/20 | 28/06/21 | 13/06/22 | 12/04/23 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net sales 1 | 3.557 | 3.719 | 4.32 | 4.259 | 4.067 | 4.185 |
EBITDA 1 | 0.1133 | 0.0787 | -1.241 | 0.004273 | -0.2921 | - |
EBIT 1 | -0.2371 | -0.2585 | -1.578 | -0.372 | -0.7275 | -0.2052 |
Operating Margin | -6.67% | -6.95% | -36.52% | -8.73% | -17.89% | -4.9% |
Earnings before Tax (EBT) 1 | -0.3814 | -0.4581 | -1.473 | -0.5418 | -3.532 | -1.286 |
Net income 1 | -0.4555 | -0.512 | -1.519 | -0.7697 | -3.532 | -1.302 |
Net margin | -12.8% | -13.77% | -35.16% | -18.07% | -86.85% | -31.11% |
EPS | - | - | -28.09 | -3.401 | -10.97 | -0.3835 |
Free Cash Flow 1 | -0.8298 | -0.602 | - | -1.362 | - | 0.6428 |
FCF margin | -23.33% | -16.19% | - | -31.98% | - | 15.36% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 23/11/18 | 10/05/19 | 10/06/20 | 28/06/21 | 13/06/22 | 12/04/23 |
Balance Sheet Analysis
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net Debt 1 | 2.6 | 2.14 | 1.84 | 1.55 | 1.8 | 1.18 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 22.98 x | 27.17 x | -1.484 x | 363.4 x | -6.159 x | - |
Free Cash Flow 1 | -0.83 | -0.6 | - | -1.36 | - | 0.64 |
ROE (net income / shareholders' equity) | -88.4% | -46.3% | -94.4% | -31.8% | -219% | -2,030% |
ROA (Net income/ Total Assets) | -1.96% | -2.03% | -11.3% | -2.34% | -5.17% | -1.93% |
Assets 1 | 23.25 | 25.23 | 13.43 | 32.94 | 68.3 | 67.52 |
Book Value Per Share | - | - | 32.20 | 13.70 | 0.3600 | 0 |
Cash Flow per Share | - | - | 0.1400 | 0.5000 | 0.1500 | 0.0100 |
Capex 1 | 0 | 0 | - | 0.01 | - | 0 |
Capex / Sales | 0.08% | 0.03% | - | 0.32% | - | 0.09% |
Announcement Date | 23/11/18 | 10/05/19 | 10/06/20 | 28/06/21 | 13/06/22 | 12/04/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-3.52% | 3.08M | |
+25.95% | 28.56B | |
+10.61% | 18.62B | |
+4.59% | 12.99B | |
+10.39% | 11.19B | |
+18.02% | 4.92B | |
-13.44% | 3.66B | |
+37.11% | 3.51B | |
+3.35% | 3.45B | |
+10.90% | 3.15B |
- Stock Market
- Equities
- VE Stock
- Financials Visibilia Editore S.p.A.